AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Atrium Therapeutics, Inc.

$8.27 -$6.48 (-43.93%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$8.26
Day Range
$7.88$8.31
Year Range
$7.49$16.77
Market Cap
141.46M
AVG Volume
257.23K
Trailing/Forward PE
-2.15/-
PEG ratio
0.36
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Revenue (USD) · Q
05M10M15M20M25 Q325 Q426 Q126 Q2
RNA Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q23M
26 Q119.64M
25 Q4859K
25 Q30
Net Income (USD) · Q
-60M-40M-20M025 Q325 Q426 Q126 Q2
RNA Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-20.19M
26 Q1-16.63M
25 Q4-48.07M
25 Q3-8.29M
Operating Income (USD) · Q
-60M-40M-20M025 Q325 Q426 Q126 Q2
RNA Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-22.62M
26 Q1-17.28M
25 Q4-48.03M
25 Q3-8.46M
EBITDA · Q
Cash Flows · Q
EPS · Q
Expenses · Q
Cash & Debt · Q
Debt ratios · Q
Margins · Q
Return on Capital · Q
Shares Outstanding · Q
Dividends (USD) · Q
Employee Count
Book Value Per Share · Q
Total Assets · Q
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: RNA

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 12 Nov 2026.

Atrium Therapeutics, Inc.
RNA
Stockpicker

Video analysis: RNA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: RNA

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.